E Di Gennaro - JoVE Visualize

Showing results (1-10 of 16) with videos related to

Pageof 2

Sort By:

Current Drug Targets|April 29, 2005

Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylaseA Budillon, F Bruzzese, E Di Gennaro, et al.

Amino Acids|August 4, 2004

Acetylation of proteins as novel target for antitumor therapy: review articleE Di Gennaro, F Bruzzese, M Caraglia, et al.

British Journal of Cancer|December 10, 1999

8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factorA Budillon, E Di Gennaro, M Caraglia, et al.

Optics Express|June 12, 2008

Pendellösung effect in photonic crystalsS Savo, E Di Gennaro, C Miletto, et al.

FEBS Letters|April 24, 1999

Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMPM Caraglia, E Di Gennaro, D Barbarulo, et al.

Lung Cancer (Amsterdam, Netherlands)|January 28, 2009

Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancerA Luciani, C Bertuzzi, G Ascione, et al.

Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005

Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cellsM Caraglia, G Giuberti, M Marra, et al.

Physical Review Letters|April 12, 2006

Experimental evidence of s-wave superconductivity in bulk CaC6G Lamura, M Aurino, G Cifariello, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, P Comella, F Rivellini, et al.

Cell Death & Disease|May 25, 2013

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cellsM R Milone, B Pucci, F Bruzzese, et al.

Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:

Pageof 2

Current Drug Targets|April 29, 2005

Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylaseA Budillon, F Bruzzese, E Di Gennaro, et al.

Amino Acids|August 4, 2004

Acetylation of proteins as novel target for antitumor therapy: review articleE Di Gennaro, F Bruzzese, M Caraglia, et al.

British Journal of Cancer|December 10, 1999

8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factorA Budillon, E Di Gennaro, M Caraglia, et al.

Optics Express|June 12, 2008

Pendellösung effect in photonic crystalsS Savo, E Di Gennaro, C Miletto, et al.

FEBS Letters|April 24, 1999

Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMPM Caraglia, E Di Gennaro, D Barbarulo, et al.

Lung Cancer (Amsterdam, Netherlands)|January 28, 2009

Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancerA Luciani, C Bertuzzi, G Ascione, et al.

Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005

Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cellsM Caraglia, G Giuberti, M Marra, et al.

Physical Review Letters|April 12, 2006

Experimental evidence of s-wave superconductivity in bulk CaC6G Lamura, M Aurino, G Cifariello, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, P Comella, F Rivellini, et al.

Cell Death & Disease|May 25, 2013

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cellsM R Milone, B Pucci, F Bruzzese, et al.

Pageof 2